期刊文献+

Avastin在眼部新生血管性疾病中的应用进展 被引量:19

Applied development of Avastin for ocular neovascular disease
下载PDF
导出
摘要 眼部新生血管性疾病是损害人类视力的主要因素之一,特别是视网膜新生血管性疾病。多年来,国内外许多学者对有关眼部新生血管性疾病的防治工作进行了大量的基础和临床研究,尚未取得预期的效果。随着单克隆抗体Avastin的诞生,眼部新生血管性疾病的治疗已获得显著效果,现将Avastin治疗眼部新生血管性疾病的相关应用进展作一综述。  Neovascular disease of eyeball,especially that of retina,was one of captial factors for injury to human visual acuity.For many years,experts around mainland and overseas have carried out a lot of basic and clinical studies about the treatment of eyeball neovascular disease and have hardly received any prospective result.With the appearance of monoclonal antibody Avastin,which has shown a significant role in the treatment of ocular neovascular disease.This article summarizes the applied development of Avastin for ocular neovascular disease.
出处 《眼科新进展》 CAS 2007年第11期874-877,共4页 Recent Advances in Ophthalmology
关键词 AVASTIN 眼部新生血管性疾病 Avastin ocular neovascular disease
  • 相关文献

参考文献40

  • 1Folkman J,D'Amore PA.Blood vessel formation:what is its molecular basis[J]?Cell 1996;87(7):1153-1155.
  • 2Meyer-Schwickerath R,Pfeiffer A,Blum WF,Freyberger H,Klein M,Lsche C,et al.Vitreous levels of the insulin-like growth factorsⅠandⅡ,the insulin-like growth factor binding proteins 2 and 3 increase in neovascular eye disease[J].Clin Invest 1993;92:2620-2625.
  • 3Amin R,Ruklin JE,Frank RN.Growth factor localization in choroidal neovascular membranes of age-related macular degeneration[J].Invest Ophthalmol Vis Sci 1994;35:3178-3180.
  • 4Asano M,Yukita A,Matsumoto T,Kondo S,Suzuki H.Inhibition of tumor growth and metachoresis by an immuno-neutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor[J].Cancer Res 1995;55(22):5296-5301.
  • 5Meyer M,Clauas M,Lepple-Wienhues AL.A novel vascular endothelial growth factor encoded by Orf virus,VEGF-E mediates angiogenesis via signaling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinase[J].EMBO J 1999;18(2):363-374.
  • 6Neufeld G,Cohen T,Gengrinovitch S,Poltorak Z.Vascular endothelial growth factor (VEGF) and its receptors[J].FASEB J 1999;13(1):9-22.
  • 7Bhisitkul RB.Vascular endothelial growth factor biology:clinical implications for ocular treatments[J].Br J Ophthalmol 2006;90:1542-1547.
  • 8Cross MJ,Claeason-Welah I.FGF and VEGF function in an-giogenesis:signaling pathways,biological responses and therapeutic inhibition[J].Trends Pharmacol Sci 2001;22(4):201-207.
  • 9de Vries C,Escobedo JA,Ueno H,Houck K,Ferrara N,Williams LT.The fms-like tyrosine kinase,a receptor for vascular endothelial growth factor[J].Science 1992;255:989-991.
  • 10Cohen AF,Van Bronswijk H.New medications:bevacizumab[J].Ned Tijdschr Geneeskd 2006;150(40):2194-2195.

二级参考文献65

  • 1马立,赵本严,狄雅芬.前部视网膜冷凝联合小梁切除术治疗新生血管性青光眼[J].中华眼科杂志,1996,32(2):118-122. 被引量:21
  • 2Del Priore LV,Ya-Hui Kuo,Tezel TH.Age-Related changes in human RPE cell density and apoptosis proportion in situ.Invest Ophthalmol Vis Sci,2002,43:3312-3318.
  • 3Holz FG,Pauleikhoff D,Klein R,et al.Pathogenesis of lesion in late age-related macular disease.Arch Ophthalmol,2004,137:504-510.
  • 4Gilbert Grand M,Bressler NM,Brown GC.Basic and clinical science course section 12,retina and vitreous.San Francisco:American Academy of Ophthalmology,1998-1999.46-48.
  • 5Kamizuru H,Kimura H,Yasukawa T,et al.Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.Invest Ophthalmol Vis Sci,2001,42:2664-2672.
  • 6Grunwald JE,Metelitsina TI,DuPont JC,et al.Reduced foveolar choroidal blood flow in eyes with increasing AMD severity.Invest Ophthalmol Vis Sci,2005,46:1033 1038.
  • 7Welge-Lussen UC,Fuchshofera R,Kampik A.Influence of hypoxia in the early and late changes of age related macular degeneration.Invest Ophthalmol Vis Sci,2004,45:3383.
  • 8Johnson PT,Lewis GP,Talaga KC,et al.Drusen-Associated Degeneration in the Retina.Invest Ophthalmol Vis Sci,2003,44:4481-4488.
  • 9Friedman E.Update of the vascular model of AMD.Br J Ophthalmol,2004,88:161-163.
  • 10Reme CE,Grimm C,Hafezi F,et al.Why study rod cell death in retinal degenerations and how? Doc Ophthalmol,2003,106:2529.

共引文献64

同被引文献229

引证文献19

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部